1. Home
  2. KRKR vs ADVB Comparison

KRKR vs ADVB Comparison

Compare KRKR & ADVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 36Kr Holdings Inc.

KRKR

36Kr Holdings Inc.

HOLD

Current Price

$3.24

Market Cap

7.0M

ML Signal

HOLD

ADVB

Advanced Biomed Inc.

HOLD

Current Price

$5.30

Market Cap

6.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KRKR
ADVB
Founded
2010
2014
Country
China
United States
Employees
N/A
31
Industry
Business Services
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.0M
6.2M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
KRKR
ADVB
Price
$3.24
$5.30
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
12.1K
281.3K
Earning Date
03-17-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$1.26
Revenue Growth
N/A
N/A
52 Week Low
$2.87
$0.19
52 Week High
$21.36
$7.59

Technical Indicators

Market Signals
Indicator
KRKR
ADVB
Relative Strength Index (RSI) 44.36 49.48
Support Level $3.11 $0.33
Resistance Level $5.09 $5.71
Average True Range (ATR) 0.35 0.57
MACD -0.03 -0.13
Stochastic Oscillator 42.26 29.29

Price Performance

Historical Comparison
KRKR
ADVB

About KRKR 36Kr Holdings Inc.

36KR Holdings Inc is a holding company and conducts its business mainly through its subsidiaries, a VIE, and subsidiaries of the VIE. The Group is engaging in providing content and business services to new economy participants in the PRC. Its content production process includes content creation, content editing, screening and monitoring, and content distribution. The Group mainly generates revenues from providing online advertising services, enterprise value-added services, and subscription services. The Group's principal operations and geographic markets are substantially located in PRC.

About ADVB Advanced Biomed Inc.

Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.

Share on Social Networks: